Co-Author
This page shows the publications co-authored by Sharon Lutz and Rachel Kelly.
Connection Strength
0.658
-
Pharmacometabolomics of Bronchodilator Response in Asthma and the Role of Age-Metabolite Interactions. Metabolites. 2019 Sep 07; 9(9).
Score: 0.208
-
Pharmacogenetics of Bronchodilator Response: Future Directions. Curr Allergy Asthma Rep. 2021 12 27; 21(12):47.
Score: 0.061
-
Pharmaco-Metabolomics of Inhaled Corticosteroid Response in Individuals with Asthma. J Pers Med. 2021 Nov 04; 11(11).
Score: 0.060
-
A polygenic risk score for asthma in a large racially diverse population. Clin Exp Allergy. 2021 11; 51(11):1410-1420.
Score: 0.060
-
Age by Single Nucleotide Polymorphism Interactions on Bronchodilator Response in Asthmatics. J Pers Med. 2021 Jan 19; 11(1).
Score: 0.057
-
Genome-wide interaction study reveals age-dependent determinants of responsiveness to inhaled corticosteroids in individuals with asthma. PLoS One. 2020; 15(3):e0229241.
Score: 0.054
-
Plasmalogens Mediate the Effect of Age on Bronchodilator Response in Individuals With Asthma. Front Med (Lausanne). 2020; 7:38.
Score: 0.054
-
Expression of SMARCD1 interacts with age in association with asthma control on inhaled corticosteroid therapy. Respir Res. 2020 Jan 28; 21(1):31.
Score: 0.054
-
Longitudinal analysis of bronchodilator response in asthmatics and effect modification of age-related trends by genotype. Pediatr Pulmonol. 2019 02; 54(2):158-164.
Score: 0.050
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.